CN Patent

CN110225762A — 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Assigned to Pharmaceuticals Co · Expires 2019-09-10 · 7y expired

What this patent protects

提供了一种通过植入式递送装置向受试者施用连续皮下剂量的胰高血糖素样肽‑1(GLP‑1)类似物的方法，其中所述受试者在所述植入式递送装置植入之后并且在连续皮下给药所述GLP‑1类似物期间通过口服共同施用药物。

USPTO Abstract

提供了一种通过植入式递送装置向受试者施用连续皮下剂量的胰高血糖素样肽‑1(GLP‑1)类似物的方法，其中所述受试者在所述植入式递送装置植入之后并且在连续皮下给药所述GLP‑1类似物期间通过口服共同施用药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN110225762A
Jurisdiction
CN
Classification
—
Expires
2019-09-10
Drug substance claim
No
Drug product claim
No
Assignee
Pharmaceuticals Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.